ASH Clinical News September 2017 New | Page 21

The AmericAn SocieTy of hemATology preSenTS:
ACUTE MYELOID LEUKEMIA
MATTERS:
Multidisciplinary Approach To Testing and Diagnosis,
Evaluation of Risk, and Personalized Treatment Selection
Are you recognizing and
diagnosing Aml promptly?
Are you confident with disease classification and
risk stratification for your patients with Aml?
earn 5.5 cme credits/cne contact hours at a complimentary summit
friday, July 28, 2017
minneApoliS, mn friday, october 20, 2017
durhAm, nc friday, october 27, 2017
philAdelphiA, pA
8:00 Am –2:30 pm
national marrow donor
program © / Be The match ©
500 n 5th Street 8:00 Am –2:30 pm
The Washington duke inn
& golf club
3001 cameron Boulevard 8:00 Am –2:30 pm
chemical heritage foundation
315 chestnut Street
Who should attend?
hematologists • medical oncologists • pathologists • hematopathologists • medical laboratory Scientists
pathologists’ Assistants • physician Assistants • hematology and oncology nurse practitioners • clinical nurses
register today!
www.Amlmatters.org or call 866-856-1998
STeering commiTTee
The goal of the summits is to improve the diagnosis
and treatment of Acute Myeloid Leukemia patients.
Participants will actively engage in multidisciplinary,
interactive small-group activities, including:
• A case-based tumor board
• Diagnosing AML
Jessica K. Altman, md (chair) heidi Klepin, md
Northwestern University
Feinberg School of Medicine Wake Forest Baptist Health
Annemarie Block, phd, fAcmg Stanford University
Medical Center
Roswell Park Cancer Institute
• Treatment decision-making
linda J. Burns, md
• MRD/CR1 and the role of transplants
National Marrow Donor Program/
Be The Match
• Relapsed refractory disease
Funded by an independent educational grant from Celgene Corporation.
Bruno c. medeiros, md
martin Tallman, md
Memorial Sloan Kettering
Cancer Center
robert paul hasserjian, md Kathleen Wiley, rn, mSn,
AocnS
Harvard Medical School Oncology Nursing Society
crediT deSignATion STATemenTS:
For Physicians: The American Society of Hematology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
ASH designates this live activity for a maximum of 5.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For Nurses: The Oncology Nursing Society is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
ONS is approved as a provider of continuing education by the California Board of Registered Nursing, Provider #2850. This activity is awarded 5.5 contact hours of continuing nursing education for RNs.
Hosted in partnership by